EXPERIENCE WITH RAPTEN RAPID USING IN THE TREATMENT OF ARTICULAR SYNDROME IN RHEUMATOID ARTHRITIS

Abstract

Summary Our aim was to study the clinical efjicacy of Rapten rapid, its effect on the activity of inflammatory process, parameters of immunity in rheumatoid arthritis as compared with other widely used NSAIDs: sodium diclofenac, Indometacin, Ibuprofen and also to clarify the mechanism of action of above drugs. The study included 110 RA patients which were divided into 4 groups. Pts of the I s' group toolc Rapten rapid (n=50), 2 ml - sodium diclofenac (n—20), 3d - Indometacin (n—20), 4' h - Ibuprofen (n—20). Al the result of the study it was found that Rapten rapid effectively reduces pain syndrome in rheumatoid arthritis, does not give preference to other anti-inflammatory drugs on analgetic and anti-inflammatory effect, has positive influence on laboratory indices of inflammation rendering thus more speedy analgetic effect demonstrated averagely 2 days faster as compared with other NSAJDs. Frequency of side-effects during Rapten rapid application does not reliably differ from other NSAIDs. Rapten rapid possesses immunomodulatory effect demonstrated by decreasing the level of serum IgA, activity of 5‘nucleotidase in lymphocytes, neutrophils, monocytes and myeloperoxidase in monocytes.

Keywords

• rheumatoid arthritis
• non-steroid anti-inflammutorv drugs
• pain syndrome
• immunomodulatory effect